Divis Laboratories Ltd reported INR200.33B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Aurobindo Pharma INR 585.02B 59.57B Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Lupin INR 383.65B 48.64B Mar/2026
Moderna USD 11.49B 850M Mar/2026
Organon & Co USD 13B 129M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Tilray USD 2.1B 15.95M Sep/2025
Viatris USD 36.83B 358.5M Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026